Resources This book is available in Oxford Scholarship Online - view abstracts and keywords at book and chapter level.
Related Categories
|
Also Recommended
|
|
|
Incentives, organization, and financing
Joan Costa-Font, Christophe Courbage...
£34.99
|
|
|
|
|
Revised Fourth Edition
David M B Hall, David Elliman
£24.99
|
|
|
|
|
|
Robert C Tasker, Robert J McClure...
£32.99
|
|
|
|
|
Economic Evaluation in Child Health
Edited by Wendy Ungar
336 pages
|
31 black-and-white line drawings
|
234x156mm
978-0-19-954749-4
|
Paperback
|
08 October 2009
Price:
£34.99 £8.74
Please note, this offer price only applies to individual customers when ordering direct from Oxford University Press, while stock lasts. No further discounts will apply. If you are a bookseller, please contact your OUP sales representative.
|
|
|
|
|
- This is the first English textbook to focus on the application of health economic evaluation methods to child health
- The book allows researchers to consider the best approaches for conducting health economic research in children, and assists decision-makers to make better decisions regarding the allocation of health care resources
- The text examines the state-of-the-art in economic evaluation for prominent child health conditions, and raises awareness regarding how child health affects not only the child, but the family, the community, schools and society
- Topics include important issues for child health in developing countries, and will benefit the conduct of research and the use of evidence for improving child health globally
Guidelines for conducting health economic evaluations have become increasingly standardized, however they don't address the unique concerns of the paediatric population. The challenges of measuring costs and consequences in children, from neonate to late adolescence, are numerous and complex. With the growing acceptance of economic evidence to guide decisions in health systems facing economic constraints, it is imperative that these challenges be considered so that this population is not left out of evidence-based decisions. The time has come
for a textbook to address economic evaluation in child health.
This book is divided into three sections: Methods, Applications, and Using evidence for decision-making, with chapters contributed by international experts. The Methods section presents detailed discussions of measuring lifetime costs and consequences, capturing productivity losses, obtaining unbiased self- and proxy reports, incorporating externalities, choosing valid outcome measures, assessing utility, and designing studies using value of information. The Applications section reviews economic evidence in common childhood conditions and areas of investigation, including newborn screening, harm prevention, mental health services, brain injury, asthma, and immunization. The final section explores the use
of economic evidence in decision-making, and includes a description of the WHO-CHOICE approach, the role of clinical research, how to value health gains by children, and the emerging field of health technology assessment. In addition to an emphasis on methods, a deliberate effort was made to include issues relevant to developing countries, where the burden of childhood disease is greatest, and for whom high quality economic evidence is critical.Readership: Health services and health economic researchers at a postgraduate level, users of health economic evidence such as health practitioners, institution and government decision-makers, and agencies involved in evidence synthesis and health technology assessment.
Also those in public health, health policy, clinical epidemiology and health administration.
|
|
|
Edited by Wendy Ungar, Senior Scientist, Child Health Evaluative Sciences, The Hospital for Sick Children; Associate Professor, Department of Health Policy, Management and Evaluation, The University of Toronto, Ontario, Canada Contributors:
Moses Aikins, Senior Lecturer, School of Public Health, Department of Health Policy, Planning and Management, College of Health Sciences, University of Ghana, Legon, Accra, Ghana
Philippe Beutels, Senior Lecturer, Health Economics, Centre for Health Economics Research and Modeling Infectious Diseases (CHERMID), Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute
(VAXINFECTIO), University of Antwerp, Antwerp, Belgium
Katherine B. Bevans, Assistant Research Professor, Division of General Pediatrics,
The Children's Hospital of Philadelphia, Philadelphia, USA
Robert E. Black, Edgar Berman Professor and Chair, Johns Hopkins Bloomberg School of Public Health, Department of International Health, Johns Hopkins University, Baltimore, USA
Werner B.F. Brouwer, Department of Health Policy & Management and Institute for Medical Technology Assessment, Erasmus University Medical Centre / Erasmus University, Rotterdam, The Netherlands
Sarah Byford, Senior Lecturer, King's College London, Institute of Psychiatry, De Crespigny Park, London, UK
Jonathan D. Campbell, Senior Post-Doctoral Fellow,
Pharmaceutical Outcomes, Research and Policy Program, School of Pharmacy, University of Washington, Seattle, USA
Vania Costa, Research Associate, Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
Gillian Currie, Assistant Professor, Faculty of Medicine, Departments of Paediatrics and Community Health Sciences, University of Calgary, Calgary, Canada
Sarah Curtis, Assistant Professor, Division of Pediatric Emergency Medicine, Department of Pediatrics, University of Alberta, Edmonton, Canada
Kim Dalziel, Senior Research Fellow, Health Economics and Policy Group, Division of Health Sciences, University of South Australia, Adelaide, Australia
David B. Evans, Director, Department of Health Systems
Financing, World Health Organization, Geneva, Switzerland
Christopher B. Forrest, Mary D. Ames Professor of Pediatrics and Advocacy, The Children's Hospital of Philadelphia, Philadelphia, USA
Tessa Tan-Torres Edejer, Coordinator, Costs, Effectiveness, Expediture and Priority Setting (CEP), Health System Financing, Health Systems and Services, World Health Organization, Geneva, Switzerland
E. Michael Foster, Professor, Maternal and Child Health and Health Policy and Administration, School of Public Health, University of North Carolina, Chapel Hill, USA
Andreas Gerber, Institute for Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany
Y. Ingrid Goh, Department of Pharmaceutical Science, University of
Toronto, Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, Canada
Scott D. Grosse, Senior Health Economist, Office of the Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, National Center on Birth Defects and Developmental Disabilities, Atlanta, USA
Raymond Hutubessy, Economist, Initiative for Vaccine Research (IVR), World Health Organization (WHO), Geneva, Switzerland
Terry Klassen, Professor and Chair, Regional Program Clinical Director Child Health, Capital Health, Department of Pediatrics, University of Alberta, Edmonton, Canada
Gideon Koren, Senior Scientist and Director, The Motherisk Program, Professor of Medicine, Pediatrics and
Physiology/Pharmacology, The University of Toronto, Ivey Chair in Molecular Toxicology, The University of Western Ontario, The Hospital for Sick Children, Toronto, Canada
Stavros Petrou, Health Economist, National Perinatal Epidemiology Unit, University of Oxford (Old Road Campus), Oxford, England
Ali I. Raja, Assistant Professor, Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, USA
Leonie Segal, Professor, Health Economics, Health Economics and Policy Group, Division of Health Sciences, University of South Australia, Adelaide, Australia
Donald S. Shepard, Professor, Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, USA
Jose A. Suaya, Schneider Institutes for
Health Policy, Heller School, Brandeis University, Waltham, USA
Sean D. Sullivan, Professor of Pharmacy, Public Health and Medicine; Director, Pharmacetical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, USA
Lillian Sung, Scientist and Assistant Professor, Department of Paediatrics, University of Toronto, Department of Paediatric Haematology/Oncology, Division of Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
J. Mick Tilford, Associate Professor, Department of Pediatrics and Health Policy Management, College of Medicine, University of Arkansas for Medical Sciences, Center for Applied Research and Evaluation, Little Rock, USA
Wendy J. Ungar, Senior Scientist,
Associate Professor, The Hospital for Sick Children Research Institute, University of Toronto, Division of Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
N. Job A. van Exel, MSc, Health Economist, Department of Health Policy & Management and Institute for Medical Technology Assessment, Erasmus University Medical Centre / Erasmus University, Rotterdam, The Netherlands
Damian G. Walker, Professor, Health Economics, Health Systems Program, Bloomberg School of Public Health, Department of International Health, Johns Hopkins University, Baltimore, USA
Andrew R. Willan, Senior Scientist and Professor, Public Health Sciences, University of Toronto, The Hospital for Sick Children Research Institute, Child Health Evaluative
Sciences, The Hospital for Sick Children, Toronto, Canada
Lara J. Wolfson, Scientist, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
|
|
|
Methods
1: Wendy J. Ungar & Andreas Gerber: The uniqueness of child health and challenges to measuring costs and consequences
2: Katherine Bevans & Christopher B. Forrest: The reliability and validity of children's and adolescents' self-reported health
3: Werner B.F. Brouwer, N. Job A. van Exel & J. Mick Tilford: Incorporating caregiver and family effects in economic evaluations of child health
4: Lillian Sung, Stavros Petrou & Wendy J. Ungar: Measurement of health utilities in children
5: Andrew R Willan: The use of value of information methods in the design and evaluation of clinical trials
Applications
6: Scott D. Grosse: Economic evaluations of newborn screening
7: Kim Dalziel & Leonie Segal: Economic evaluation in child protection: what are the special challenges? Part 1. Economic evaluation in child protection
E. Michael Foster: Economic evaluation in child protection: what are the special challenges? Part 2. Economic evaluation in child welfare
Y. Ingrid Goh, Gideon Koren & Wendy J. Ungar: Economic evaluation in child protection: what are the special challenges? Part 3. Economic evaluation in Fetal Alcohol Spectrum Disorder
8: Sarah Byford: Obstacles to the economic evaluation of specialist child and adolescent mental health services
9: J. Mick Tilford & Ali I. Raja: Is more aggressive treatment of pediatric traumatic brain injury worth it?
10: Jonathan D. Campbell & Sean D. Sullivan: Economic evaluations in the management of paediatric asthma
11: Damian G Walker, Philippe Beutels & Raymond Hutubessy: Economic evaluation of childhood vaccines
12: Donald S. Shepard & Jose A. Suaya: Economic evaluation of dengue prevention
Using Evidence for Decision-Making
13: Tessa Tan-Torres Edejer, Moses Aikins, Robert Black, Lara Wolfson, Raymond Hutubessy & David B. Evans: Economic evaluations of interventions for children in the developing world: the WHO-CHOICE approach
14: Gillian Currie, Sarah Curtis & Terry Klassen: Evidence-based decision-making in child health: the role of clinical research and economic evaluation
15: Stavros Petrou: Should health gains by children be given the same value as health gains by adults in an economic evaluation framework?
16: Vania Costa & Wendy J. Ungar: Health-technology assessment in child health
|
|
|
|
|
|
|
|
|
Recently Viewed
|
|
|
Intimacy, Identification, and the Social Nature of Persons
Bennett W. Helm
£45.00
|
|
|
|
|
Godfrey Boyle
£33.99
|
|
|
|
|
A. John Camm, Thomas F. Lüscher...
£225.00
|
|
|
|
|
The specification in this catalogue, including without limitation price, format, extent, number of illustrations, and month of publication, was as accurate as possible at the time the catalogue was compiled. Occasionally, due to the nature of some contractual restrictions, we are unable to ship a specific product to a particular territory. Jacket images are provisional and liable to change before publication.
|
|
